1. Catheter-associated primary bloodstream infections: Epidemiology and preventive methods

   • P. Gastmeier
   • K. Weist
   • H. Rüden

   OriginalPaper Pages: S1 - S6

2. Basic aspects of the pathogenesis of staphylococcal polymer-associated infections

   • C. von Eiff
   • C. Heilmann
   • G. Peters

   OriginalPaper Pages: S7 - S10

3. Prevention of infections caused by central venous catheters-established and novel measures

   • A. Bach

   OriginalPaper Pages: S11 - S15

4. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters

   • J. -P. Guggenbichler
   • M. Böswald
   • T. Krall

   OriginalPaper Pages: S16 - S23

5. The erlanger silver catheter:In vitro results for antimicrobial activity

   • T. Bechert
   • M. Böswald
   • J. -P. Guggenbichler

   OriginalPaper Pages: S24 - S29

6. Thrombogenicity testing of central venous cathetersin vitro

   • M. Böswald
   • S. Lugauer
   • J. -P. Guggenbichler

   OriginalPaper Pages: S30 - S33

7. Analysis of the acute cytotoxicity of the erlanger silver catheter

   • J. Greil
   • T. Spies
   • J. -P. Guggenbichler

   OriginalPaper Pages: S34 - S37

8. Biocompatibility testing of a new silver-impregnated catheterin vivo

   • M. Böswald
   • K. Mende
   • J. -P. Guggenbichler

   OriginalPaper Pages: S38 - S42

9. Thermoplastic polyurethane—The material used for the erlanger silver catheter

   • T. Hentschel
   • H. Münstedt

   OriginalPaper Pages: S43 - S45

10. Determination of the silver ion release from polyurethanes enriched with silver

    • R. M. Joyce-Wöhrmann
    • H. Münstedt

    OriginalPaper Pages: S46 - S48

11. A new scoring system for the clinical diagnosis of catheter-related infections

    • S. Lugauer
    • A. Regenfus
    • J. -P. Guggenbichler

    OriginalPaper Pages: S49 - S53

12. Silver catheter study: Methods and results of microbiological investigations

    • C. Schoerner
    • J. -P. Guggenbichler
    • A. Regenfus

    OriginalPaper Pages: S54 - S55

13. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter

    • M. Böswald
    • S. Lugauer
    • J. -P. Guggenbichler

    OriginalPaper Pages: S56 - S60

14. Clinical study of the erlanger silver catheter—Data management and biometry

    • P. Martus
    • C. Geis
    • J. -P. Guggenbichler

    OriginalPaper Pages: S61 - S68

15. Reducing catheter-associated infections with silver-impregnated catheters in long-term therapy of children

    • R. T. Carbon
    • S. Lugauer
    • J. -P. Guggenbichler

    OriginalPaper Pages: S69 - S73

16. Catheter-associated infections in urology: Possible use of silver-impregnated catheters and the erlanger silver catheter

    • W. Rösch
    • S. Lugauer

    OriginalPaper Pages: S74 - S77

17. Economic aspects of innovations in medical technology

    • P. Oberender
    • S. Ruckdäschel
    • J. -P. Guggenbichler

    OriginalPaper Pages: S78 - S80